Technology area: Biotechnology & Pharmaceuticals
1 pending office actions • 1 art units • 1 examiners • 0 of 1 (0%) have an AI response strategy ready
Csl Behring (Australia) Pty Ltd. is managing 1 pending office action within the Biotechnology & Pharmaceuticals technology area. The prosecution is currently limited to 1 distinct art unit, which suggests a highly specialized focus for the company's active applications. With an examiner involved, the company's immediate patent prospects are concentrated. This technology area often requires detailed biological data and specific pharmaceutical claim structures, which will be evaluated within the art unit.
The busiest examiner for this portfolio is ROBINSON, HOPE A, who is responsible for the pending office action. This examiner oversees the entirety of the company's current pending workload. In the context of Biotechnology & Pharmaceuticals, where examination can be complex, having ROBINSON, HOPE A and the art unit involved simplifies the administrative burden but increases the impact of individual examiner discretion. The company's current strategy relies on navigating the specific expectations of the examiner to advance its intellectual property position. Practitioners must ensure that the response to the 1 pending office action addresses the technical nuances favored by the examiner to secure an allowance.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| Multi-statute (no §101) | 1 (100%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| ROBINSON, HOPE A | 1 | 67.7% | +43.1% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18869637 | METHOD OF FILTERING SOLIDS FROM A SOLUTION DERIVED FROM PLASMA | ROBINSON, HOPE A | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18869637 | METHOD OF FILTERING SOLIDS FROM A SOLUTION DERIVED FROM PLASMA | ROBINSON, HOPE A | — |
| Art Unit | Apps |
|---|---|
| 1656 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18869637 | METHOD OF FILTERING SOLIDS FROM A SOLUTION DERIVED FROM PLASMA | ROBINSON, HOPE A | 1656 | §102§103 | Non-Final OA | — | Pending | Nov 26, 2024 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial